PFM Health Sciences’s Sanofi SNY Stock Holding History

PFM Health Sciences’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-176,413	Closed	-$8.55M	–	98
2025 Q4	$8.55M	Buy	+176,413	New	+$8.74M	0.85%	38

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PFM Health Sciences's SNY Position: Q1 2026 in Review

PFM Health Sciences sold out of Sanofi (SNY) in Q1 2026, closing a stake of 176,413 shares — an estimated $8.55M sold.

PFM Health Sciences first reported a position in SNY in Q4 2025 and held it in 1 quarter. The position peaked at $8.55M in Q4 2025. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

PFM Health Sciences reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
PFM Health Sciences sold 176,413 Sanofi shares in Q1 2026, an estimated $8.55M.
PFM Health Sciences first reported a position in Sanofi in Q4 2025 and held it in 1 quarter.
PFM Health Sciences's Sanofi position peaked at $8.55M in Q4 2025.
745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.